ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,037Medicare Part D Prescriptions Filled, Including Refills

Rank: 176 out of 1844

$1.51M Total Retail Price of All Prescriptions

Rank: 9 out of 1844

599 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,069 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$137 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HUMALOG 936 693 10 1 114
LANTUS 809 575 2 42
GLIMEPIRIDE 654 494 3 35
INSULIN SYRINGE 645 477 10 4 111
LANTUS SOLOSTAR 540 319 5 97
PEN NEEDLE 529 362 6 135
LEVOTHYROXINE SODIUM 482 362 7 1
NOVOLOG 441 330 8 84
HUMULIN N 421 347 10 9 234
METFORMIN HCL 402 290 10 8
NOVOLOG FLEXPEN 389 246 11 163
SIMVASTATIN 333 200 12 3
PRAVASTATIN SODIUM 230 193 13 10
NOVOLIN N 220 178 14 303
HUMULIN R 193 116 15 280
LISINOPRIL 177 130 16 4
AMLODIPINE BESYLATE 170 133 17 6
METFORMIN HCL ER 169 118 18 46
FENOFIBRATE 145 105 19 71
GABAPENTIN 128 70 20 15
FUROSEMIDE 118 111 21 7
CITALOPRAM HBR 98 62 22 19
ATORVASTATIN CALCIUM 97 89 23 12
HYDROCHLOROTHIAZIDE 88 67 24 9
GLIPIZIDE ER 87 73 25 79
LOSARTAN POTASSIUM 87 65 25 24
GLYBURIDE 78 76 R 27 100
HYDROCODONE-ACETAMINOPHEN 75 30 S3 28 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 52 28 20
ZETIA 72 66 30 81
GLYBURIDE MICRONIZED 71 71 R 31 243
DIOVAN 70 70 32 58
CYMBALTA 69 40 33 36
SYNTHROID 65 51 34 55
POTASSIUM CHLORIDE 62 43 35 16
OMEPRAZOLE 54 48 36 5
CRESTOR 52 36 37 30
NOVOLIN R 50 32 38 214
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.